IDH2 and central nervous system cancer: Whereas IDH mutations are involved in the initial steps of carcinogenesis, the metabolic and oxidative stress that comes with the mutation may eventually slow down tumor progression, explaining the better survival of patients carrying IDHmut gliomas [16, 17].